MedPath

Safety and Efficacy of Bronchitol in Bronchiectasis

Phase 3
Completed
Conditions
Bronchiectasis
Interventions
Drug: placebo
Registration Number
NCT00277537
Lead Sponsor
Syntara
Brief Summary

Study will assess the safety and effectiveness of 12 week treatment with the study medication, Bronchitol, in subjects with bronchiectasis (a lung disease where patients have trapped, and often infected, thick, sticky mucus). Past studies have shown Bronchitol inhalation may help to facilitate the clearance of mucus by altering its rheology (making it less thick and sticky), thereby enhancing the shift of stagnant mucus from the lungs. On completion of the double blind phase, subjects will have the opportunity to participate in a 52 week open label phase.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
354
Inclusion Criteria
  • Non cystic fibrosis bronchiectasis
  • Have FEV1 50% - 80% predicted and โ‰ฅ1.0L
  • Have chronic sputum production of >10 mL per day on the majority of days in the 3 months prior to study entry
Exclusion Criteria
  • Be using hypertonic saline or mucolytic pharmacological agents concurrently or in the 4 weeks prior to study entry
  • Have airway hyperresponsiveness as defined by a positive Aridol challenge

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
2placebo-
1Mannitol-
Primary Outcome Measures
NameTimeMethod
24 hour sputum clearance24 hours / 12 weeks
Quality of Life SGRQ12 weeks
Secondary Outcome Measures
NameTimeMethod
cough severity12 weeks
bronchial wall thickening and inflammation12 weeks
bronchiectasis symptoms12 weeks
exercise capacity12 weeks
lung function, including gas transfer12 weeks
antibiotic use12 weeks
adverse events12 weeks / 12 months
haematology, biochemistry,12 weeks / 12 months
sputum microbiology quantitative and qualitative12 weeks / 12 months

Trial Locations

Locations (22)

Royal Perth Hospital

๐Ÿ‡ฆ๐Ÿ‡บ

Perth, Western Australia, Australia

Belfast City Hospital

๐Ÿ‡ฌ๐Ÿ‡ง

Belfast, Northern Ireland, United Kingdom

St George Hospital

๐Ÿ‡ฆ๐Ÿ‡บ

Kogarah, New South Wales, Australia

Royal Prince Alfred Hospital

๐Ÿ‡ฆ๐Ÿ‡บ

Camperdown Sydney, New South Wales, Australia

Cairns Base Hospital

๐Ÿ‡ฆ๐Ÿ‡บ

Cairns, Queensland, Australia

Greenlane Hospital

๐Ÿ‡ณ๐Ÿ‡ฟ

Auckland, New Zealand

Burnside War Memorial Hospital

๐Ÿ‡ฆ๐Ÿ‡บ

Toorak Gardens, Adelaide, South Australia, Australia

Repatriation General Hospital

๐Ÿ‡ฆ๐Ÿ‡บ

Adelaide, South Australia, Australia

Norfolk and Norwich University Hospital

๐Ÿ‡ฌ๐Ÿ‡ง

Norwich, United Kingdom

Middlemore Hospital

๐Ÿ‡ณ๐Ÿ‡ฟ

Auckland, New Zealand

AARI Sir Charles Gairdner Hospital

๐Ÿ‡ฆ๐Ÿ‡บ

Perth, Western Australia, Australia

Peninsula Health Frankston Hospital

๐Ÿ‡ฆ๐Ÿ‡บ

Frankston, Victoria, Australia

The Alfred Hospital

๐Ÿ‡ฆ๐Ÿ‡บ

Melbourne, Victoria, Australia

Royal Adelaide Hospital

๐Ÿ‡ฆ๐Ÿ‡บ

Adelaide, South Australia, Australia

Papworth Hospital

๐Ÿ‡ฌ๐Ÿ‡ง

Cambridge, United Kingdom

Canberra Hospital

๐Ÿ‡ฆ๐Ÿ‡บ

Canberra, Australian Capital Territory, Australia

Royal North Shore Hospital

๐Ÿ‡ฆ๐Ÿ‡บ

St Leonards, New South Wales, Australia

Mater Adult Hospital

๐Ÿ‡ฆ๐Ÿ‡บ

Brisbane, Queensland, Australia

Bankstown Hospital

๐Ÿ‡ฆ๐Ÿ‡บ

Sydney, New South Wales, Australia

John Hunter Hospital

๐Ÿ‡ฆ๐Ÿ‡บ

Newcastle, New South Wales, Australia

Glenfield Hospital

๐Ÿ‡ฌ๐Ÿ‡ง

Leicester, United Kingdom

North West Lung Centre, Wythshawe Hospital

๐Ÿ‡ฌ๐Ÿ‡ง

Manchester, United Kingdom

ยฉ Copyright 2025. All Rights Reserved by MedPath